Tengjun Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was USD 8.52 million compared to USD 55.57 million a year ago. Net loss was USD 0.090445 million compared to net income of USD 4.14 million a year ago.